Nuvo Announces Update On Discussions With FDA Related To Approval Of Pennsaid
Sat, 10 Feb 2007 08:00 AM EST
... Nuvo Research Inc. (TSX: NRI) today provided an update on discussions with the U.S. Food and Drug Administration ("FDA") regarding the approvable letter issued by the FDA on December 28, 2006 (the "Approvable Letter") for Pennsaid, a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis. [click link for full article] ...
Related Topics
- Vaccine Testing & Approval
- Amphetamine and Dextroamphetamine ER
- Tacrolimus ointment
- Food-Related Diseases
- Water-Related Diseases
- AIDS-Related Cancers
- Mammography
- Carcinogens
- Macular Degeneration
- Tarceva
- Lymphoma, AIDS-Related
- AIDS-Related Lymphoma
- Health-Related Quality of Life
- Quality of Life, Health-Related
- Pimecrolimus Cream 1%
- Sports Injury
- Sports Injuries
- Dietary Guidelines
- Autoimmune Diseases
- Musculoskeletal Disorders

Not Signed In -


